viadrene limited
viadrene limited Company Information
Group Structure
View All
Industry
Other human health activities
Registered Address
unit 21, three springs trading estate, worcester, WR5 1BW
Website
www.viadrene.co.ukviadrene limited Estimated Valuation
Pomanda estimates the enterprise value of VIADRENE LIMITED at £157.4k based on a Turnover of £385.2k and 0.41x industry multiple (adjusted for size and gross margin).
viadrene limited Estimated Valuation
Pomanda estimates the enterprise value of VIADRENE LIMITED at £36.8k based on an EBITDA of £11.7k and a 3.15x industry multiple (adjusted for size and gross margin).
viadrene limited Estimated Valuation
Pomanda estimates the enterprise value of VIADRENE LIMITED at £50.4k based on Net Assets of £21.4k and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Viadrene Limited Overview
Viadrene Limited is a live company located in worcester, WR5 1BW with a Companies House number of 08509252. It operates in the other human health activities sector, SIC Code 86900. Founded in April 2013, it's largest shareholder is ian goodall with a 100% stake. Viadrene Limited is a established, micro sized company, Pomanda has estimated its turnover at £385.2k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Viadrene Limited Health Check
Pomanda's financial health check has awarded Viadrene Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs
2 Strong
1 Regular
7 Weak
Size
annual sales of £385.2k, make it smaller than the average company (£645k)
- Viadrene Limited
£645k - Industry AVG
Growth
3 year (CAGR) sales growth of 5%, show it is growing at a slower rate (8%)
- Viadrene Limited
8% - Industry AVG
Production
with a gross margin of 23.2%, this company has a higher cost of product (39.1%)
- Viadrene Limited
39.1% - Industry AVG
Profitability
an operating margin of 3% make it less profitable than the average company (5.5%)
- Viadrene Limited
5.5% - Industry AVG
Employees
with 1 employees, this is below the industry average (17)
1 - Viadrene Limited
17 - Industry AVG
Pay Structure
on an average salary of £27.2k, the company has an equivalent pay structure (£27.2k)
- Viadrene Limited
£27.2k - Industry AVG
Efficiency
resulting in sales per employee of £385.2k, this is more efficient (£49k)
- Viadrene Limited
£49k - Industry AVG
Debtor Days
it gets paid by customers after 110 days, this is later than average (20 days)
- Viadrene Limited
20 days - Industry AVG
Creditor Days
its suppliers are paid after 113 days, this is slower than average (17 days)
- Viadrene Limited
17 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Viadrene Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Viadrene Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 82.1%, this is a higher level of debt than the average (25.7%)
82.1% - Viadrene Limited
25.7% - Industry AVG
VIADRENE LIMITED financials
Viadrene Limited's latest turnover from April 2024 is estimated at £385.2 thousand and the company has net assets of £21.4 thousand. According to their latest financial statements, Viadrene Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||
| Other Income Or Grants | |||||||||||
| Cost Of Sales | |||||||||||
| Gross Profit | |||||||||||
| Admin Expenses | |||||||||||
| Operating Profit | |||||||||||
| Interest Payable | |||||||||||
| Interest Receivable | |||||||||||
| Pre-Tax Profit | |||||||||||
| Tax | |||||||||||
| Profit After Tax | |||||||||||
| Dividends Paid | |||||||||||
| Retained Profit | |||||||||||
| Employee Costs | |||||||||||
| Number Of Employees | 1 | 1 | 1 | 1 | 1 | 1 | |||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 2,597 | 3,246 | 2,115 | 2,644 | 2,509 | 3,136 | 3,920 | ||||
| Intangible Assets | |||||||||||
| Investments & Other | |||||||||||
| Debtors (Due After 1 year) | |||||||||||
| Total Fixed Assets | 2,597 | 3,246 | 2,115 | 2,644 | 2,509 | 3,136 | 3,920 | ||||
| Stock & work in progress | 2,000 | 2,000 | |||||||||
| Trade Debtors | 117,026 | 96,105 | 94,907 | 101,177 | 35,133 | 47,920 | 27,134 | 28,913 | 26,049 | ||
| Group Debtors | |||||||||||
| Misc Debtors | |||||||||||
| Cash | 33,935 | 7,155 | |||||||||
| misc current assets | |||||||||||
| total current assets | 117,026 | 96,105 | 94,907 | 101,177 | 35,133 | 47,920 | 27,134 | 28,913 | 26,049 | 35,935 | 9,155 |
| total assets | 119,623 | 99,351 | 97,022 | 103,821 | 37,642 | 51,056 | 31,054 | 28,913 | 26,049 | 35,935 | 9,155 |
| Bank overdraft | |||||||||||
| Bank loan | |||||||||||
| Trade Creditors | 92,044 | 75,614 | 80,377 | 77,450 | 33,316 | 37,262 | 30,404 | 24,498 | 12,213 | 14,699 | 7,657 |
| Group/Directors Accounts | |||||||||||
| other short term finances | |||||||||||
| hp & lease commitments | |||||||||||
| other current liabilities | |||||||||||
| total current liabilities | 92,044 | 75,614 | 80,377 | 77,450 | 33,316 | 37,262 | 30,404 | 24,498 | 12,213 | 14,699 | 7,657 |
| loans | |||||||||||
| hp & lease commitments | |||||||||||
| Accruals and Deferred Income | 600 | 600 | 600 | 700 | 700 | ||||||
| other liabilities | 5,537 | 10,461 | 15,324 | 25,000 | |||||||
| provisions | |||||||||||
| total long term liabilities | 6,137 | 11,061 | 15,924 | 25,700 | 700 | ||||||
| total liabilities | 98,181 | 86,675 | 96,301 | 103,150 | 34,016 | 37,262 | 30,404 | 24,498 | 12,213 | 14,699 | 7,657 |
| net assets | 21,442 | 12,676 | 721 | 671 | 3,626 | 13,794 | 650 | 4,415 | 13,836 | 21,236 | 1,498 |
| total shareholders funds | 21,442 | 12,676 | 721 | 671 | 3,626 | 13,794 | 650 | 4,415 | 13,836 | 21,236 | 1,498 |
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||
| Operating Profit | |||||||||||
| Depreciation | |||||||||||
| Amortisation | |||||||||||
| Tax | |||||||||||
| Stock | -2,000 | 2,000 | |||||||||
| Debtors | 20,921 | 1,198 | -6,270 | 66,044 | -12,787 | 20,786 | -1,779 | 2,864 | 26,049 | ||
| Creditors | 16,430 | -4,763 | 2,927 | 44,134 | -3,946 | 6,858 | 5,906 | 12,285 | -2,486 | 7,042 | 7,657 |
| Accruals and Deferred Income | -100 | 700 | |||||||||
| Deferred Taxes & Provisions | |||||||||||
| Cash flow from operations | |||||||||||
| Investing Activities | |||||||||||
| capital expenditure | |||||||||||
| Change in Investments | |||||||||||
| cash flow from investments | |||||||||||
| Financing Activities | |||||||||||
| Bank loans | |||||||||||
| Group/Directors Accounts | |||||||||||
| Other Short Term Loans | |||||||||||
| Long term loans | |||||||||||
| Hire Purchase and Lease Commitments | |||||||||||
| other long term liabilities | -4,924 | -4,863 | -9,676 | 25,000 | |||||||
| share issue | |||||||||||
| interest | |||||||||||
| cash flow from financing | |||||||||||
| cash and cash equivalents | |||||||||||
| cash | -33,935 | 26,780 | 7,155 | ||||||||
| overdraft | |||||||||||
| change in cash | -33,935 | 26,780 | 7,155 |
viadrene limited Credit Report and Business Information
Viadrene Limited Competitor Analysis
Perform a competitor analysis for viadrene limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in WR5 area or any other competitors across 12 key performance metrics.
viadrene limited Ownership
VIADRENE LIMITED group structure
Viadrene Limited has no subsidiary companies.
Ultimate parent company
VIADRENE LIMITED
08509252
viadrene limited directors
Viadrene Limited currently has 1 director, Dr Leslie Goodall serving since Jun 2015.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Leslie Goodall | United Kingdom | 71 years | Jun 2015 | - | Director |
P&L
April 2024turnover
385.2k
+30%
operating profit
11.7k
0%
gross margin
23.2%
+6.05%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
April 2024net assets
21.4k
+0.69%
total assets
119.6k
+0.2%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
viadrene limited company details
company number
08509252
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
April 2013
age
12
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
April 2024
previous names
N/A
accountant
-
auditor
-
address
unit 21, three springs trading estate, worcester, WR5 1BW
Bank
-
Legal Advisor
-
viadrene limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to viadrene limited.
viadrene limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for VIADRENE LIMITED. This can take several minutes, an email will notify you when this has completed.
viadrene limited Companies House Filings - See Documents
| date | description | view/download |
|---|
